Literature DB >> 12481255

Allelic imbalance in hereditary and sporadic prostate cancer.

Bas A J Verhage1, Kjeld van Houwelingen, T Emiel G Ruijter, Lambertus A Kiemeney, Jack A Schalken.   

Abstract

BACKGROUND: In this study, we evaluate the pattern of allelic imbalance (AI) in both sporadic prostate cancer (SPC) and hereditary prostate cancer (HPC) at loci that frequently show allelic imbalance in sporadic prostate cancer, or are believed to have a putative role in the disease.
METHODS: DNA obtained from 35 sporadic tumors and 46 hereditary tumors were tested for AI, by using a panel of 35 microsatellite markers.
RESULTS: Chromosomal regions that display high frequencies of AI (>or=30%) in HPC include 1q, 5q, 7q, 8p, 13q, 16q, 17q, 18q, and 20q. In SPC, high frequencies of AI were found at 5q, 7q, 8p, 10q, 13q. Main differences (delta >or= 20%) in AI between HPC and SPC were at 1q, 10q, 17q, 18q, and 20q.
CONCLUSION: AI at the prostate cancer susceptibility loci HPC1, PCaP, and HPC20 was seen more often in HPC compared with SPC. It appears that there are marked differences in the pattern of AI between sporadic and hereditary PCa. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12481255     DOI: 10.1002/pros.10148

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  5 in total

1.  LncRNA AC245100.4 binds HSP90 to promote the proliferation of prostate cancer.

Authors:  Rongjun Cui; Chi Liu; Ping Lin; Hui Xie; Wei Wang; Jiabin Zhao; Shan Jiang; Jie Shi; Xiaoguang Yu
Journal:  Epigenomics       Date:  2020-08-19       Impact factor: 4.778

Review 2.  Genetic susceptibility to prostate cancer: a review.

Authors:  Bas A J Verhage; Lambertus A L M Kiemeney
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

Review 3.  Signal transducer and activator of transcription 5A/B in prostate and breast cancers.

Authors:  Shyh-Han Tan; Marja T Nevalainen
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

4.  STAT5A/B gene locus undergoes amplification during human prostate cancer progression.

Authors:  Bassem R Haddad; Lei Gu; Tuomas Mirtti; Ayush Dagvadorj; Paraskevi Vogiatzi; David T Hoang; Renu Bajaj; Benjamin Leiby; Elyse Ellsworth; Shauna Blackmon; Christian Ruiz; Mark Curtis; Paolo Fortina; Adam Ertel; Chengbao Liu; Hallgeir Rui; Tapio Visakorpi; Lukas Bubendorf; Costas D Lallas; Edouard J Trabulsi; Peter McCue; Leonard Gomella; Marja T Nevalainen
Journal:  Am J Pathol       Date:  2013-05-07       Impact factor: 4.307

5.  Diagnostic value of DNA alteration: loss of heterozygosity or allelic imbalance-promising for molecular staging of prostate cancers.

Authors:  Magdalena Bryś; Monika Migdalska-Sęk; Dorota Pastuszak-Lewandoska; Ewa Forma; Karolina Czarnecka; Daria Domańska; Ewa Nawrot; Jacek Wilkosz; Waldemar Różański; Ewa Brzeziańska
Journal:  Med Oncol       Date:  2013-01-04       Impact factor: 3.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.